|
GB8730011D0
(en)
*
|
1987-12-23 |
1988-02-03 |
Smithkline Dauelsberg |
Pharmaceutical compositions
|
|
US5096716A
(en)
*
|
1988-09-01 |
1992-03-17 |
Alza Corporation |
Dosage form for administering calcium antagonist nicardipine
|
|
US5108756A
(en)
*
|
1989-01-12 |
1992-04-28 |
Pfizer Inc. |
Dispensing devices powered by lyotropic liquid crystals
|
|
US5186942A
(en)
*
|
1989-01-30 |
1993-02-16 |
Alza Corporation |
Nicardipine therapy
|
|
US5273752A
(en)
*
|
1989-07-18 |
1993-12-28 |
Alza Corporation |
Controlled release dispenser comprising beneficial agent
|
|
DE4101873C2
(de)
*
|
1991-01-23 |
1993-12-09 |
Isis Pharma Gmbh |
Peroral applizierbare Arzneiform zur Behandlung zentraler Dopaminmangelzustände
|
|
US5443459A
(en)
*
|
1991-01-30 |
1995-08-22 |
Alza Corporation |
Osmotic device for delayed delivery of agent
|
|
US5240713A
(en)
*
|
1991-09-27 |
1993-08-31 |
Alza Corporation |
Dual rate agent delivery device
|
|
KR100212353B1
(ko)
*
|
1991-10-24 |
1999-08-02 |
하비 자콥스 |
하이드로겔 전기분해에 의해 생성된 기체압력을 이용한 약물주입 시스템
|
|
US5246711A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating dysthymia
|
|
US5246710A
(en)
*
|
1992-02-27 |
1993-09-21 |
Alza Corporation |
Dosage form for treating cyclothymia
|
|
US5330762A
(en)
*
|
1992-02-27 |
1994-07-19 |
Alza Corporation |
Tandospiaine antidepressive therapy
|
|
US5858407A
(en)
*
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
|
US5185158A
(en)
*
|
1992-02-27 |
1993-02-09 |
Alza Corporation |
Dosage form comprising succinimide drug for treating depressive disorders and composition comprising same
|
|
US5688518A
(en)
*
|
1992-02-27 |
1997-11-18 |
Alza Corporation |
Antidepressive therapy
|
|
US5462741A
(en)
*
|
1992-08-06 |
1995-10-31 |
Alza Corporation |
High agent loaded controlled release dispenser
|
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
|
US6919373B1
(en)
*
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
|
US6203813B1
(en)
|
1997-01-13 |
2001-03-20 |
Lance L. Gooberman |
Pharmaceutical delivery device and method of preparation therefor
|
|
US5951538A
(en)
*
|
1997-08-07 |
1999-09-14 |
Ceramatec, Inc. |
Gas generating device for delivering beneficial agents to a body cavity
|
|
US6645192B2
(en)
*
|
1998-09-30 |
2003-11-11 |
Ivy Animal Health, Inc. |
Pellet implant system for immediate and delayed release of antiparasitic drug
|
|
US6706282B1
(en)
|
1998-11-02 |
2004-03-16 |
Evangeline Cruz |
Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
|
|
EP1652516A3
(en)
|
1998-11-02 |
2006-05-17 |
ALZA Corporation |
Osmotic controlled delivery of active agents
|
|
US6342249B1
(en)
|
1998-12-23 |
2002-01-29 |
Alza Corporation |
Controlled release liquid active agent formulation dosage forms
|
|
US6797283B1
(en)
|
1998-12-23 |
2004-09-28 |
Alza Corporation |
Gastric retention dosage form having multiple layers
|
|
US6491683B1
(en)
|
1999-09-07 |
2002-12-10 |
Alza Corporation |
Osmotic dosage form composed of an extruded polymer tube form
|
|
HUP0203860A3
(en)
|
1999-12-16 |
2004-06-28 |
Alza Corp Mountain View |
Dosage forms having a barrier layer to laser ablation
|
|
DE60325715D1
(de)
*
|
2002-04-29 |
2009-02-26 |
Alza Corp |
Methoden und darreichungsformen zur kontrollierten freisetzung von oxykodon
|
|
CN1671358A
(zh)
*
|
2002-05-31 |
2005-09-21 |
阿尔扎公司 |
用于渗透传递可变剂量的羟考酮的剂型和组合物
|
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
|
US20050232995A1
(en)
*
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
|
NZ537543A
(en)
*
|
2002-07-29 |
2007-08-31 |
Alza Corp |
Formulations and high dose osmotic dosage forms for controlled delivery of topiramate
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
KR20050095835A
(ko)
*
|
2003-01-14 |
2005-10-04 |
알자 코포레이션 |
조정된 점성층을 갖는 방법 및 제형
|
|
ATE401866T1
(de)
*
|
2003-02-11 |
2008-08-15 |
Alza Corp |
Verfahren und dosierformen mit modifizierter schichtgeometrie
|
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
PT1658054E
(pt)
*
|
2003-08-06 |
2007-09-18 |
Gruenenthal Gmbh |
''forma de dosagem que está salvaguardada de abuso''
|
|
MXPA06001548A
(es)
*
|
2003-08-06 |
2006-09-04 |
Johnson & Johnson |
Suministro uniforme de topiramato durante un periodo prolongado con formulaciones de dispersion.
|
|
US20070048228A1
(en)
*
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US8075872B2
(en)
*
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
|
DE102004032051A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
|
CA2540047A1
(en)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Oros push-stick for controlled delivery of active agents
|
|
MXPA06003451A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Formas de dosificacion osmotica para suministro controlado de alprazolam.
|
|
JP5563731B2
(ja)
*
|
2003-09-26 |
2014-07-30 |
アルザ・コーポレーシヨン |
オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
|
|
CA2540308C
(en)
*
|
2003-09-26 |
2013-08-06 |
Alza Corporation |
Drug coating providing high drug loading and methods for providing the same
|
|
JP2007516297A
(ja)
*
|
2003-12-23 |
2007-06-21 |
アルザ・コーポレーシヨン |
制御送達用薬剤組成物の溶解度を高くする方法および投薬形態物
|
|
AU2004312084A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc. |
Novel drug compositions and dosage forms of topiramate
|
|
JP2007517061A
(ja)
*
|
2003-12-29 |
2007-06-28 |
アルザ・コーポレーシヨン |
新規薬剤組成物及び投与形態物
|
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
|
DE102004032049A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
DE102004032103A1
(de)
*
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
|
EP1791520A2
(en)
*
|
2004-08-19 |
2007-06-06 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
DE102005005449A1
(de)
*
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
|
US7959938B2
(en)
*
|
2005-03-15 |
2011-06-14 |
Intarcia Therapeutics, Inc. |
Polyoxaester suspending vehicles for use with implantable delivery systems
|
|
US8778395B2
(en)
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
|
EP1933811A2
(en)
*
|
2005-09-30 |
2008-06-25 |
Alza Corporation |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
|
DK3326681T3
(da)
*
|
2005-12-30 |
2019-09-30 |
Rdd Pharma Ltd |
Indretning til behandling af analsphincteren
|
|
US20090317355A1
(en)
*
|
2006-01-21 |
2009-12-24 |
Abbott Gmbh & Co. Kg, |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US20090022798A1
(en)
*
|
2007-07-20 |
2009-01-22 |
Abbott Gmbh & Co. Kg |
Formulations of nonopioid and confined opioid analgesics
|
|
US20100172989A1
(en)
*
|
2006-01-21 |
2010-07-08 |
Abbott Laboratories |
Abuse resistant melt extruded formulation having reduced alcohol interaction
|
|
US9011930B2
(en)
*
|
2006-05-01 |
2015-04-21 |
Zycal Bioceuticals Healthcare Company, Inc. |
Nutritional supplement and use thereof
|
|
MX2008014870A
(es)
|
2006-05-30 |
2009-02-12 |
Intarcia Therapeutics Inc |
Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
|
|
EP3421031A1
(en)
|
2006-08-09 |
2019-01-02 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
|
US7538652B2
(en)
*
|
2006-08-29 |
2009-05-26 |
International Business Machines Corporation |
Electrical component tuned by conductive layer deletion
|
|
DE102007011485A1
(de)
*
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
|
MX2009011123A
(es)
|
2007-04-23 |
2009-11-02 |
Intarcia Therapeutics Inc |
Formulaciones de suspensiones de peptidos insulinotropicos y sus usos.
|
|
WO2009092601A1
(en)
*
|
2008-01-25 |
2009-07-30 |
Grünenthal GmbH |
Pharmaceutical dosage form
|
|
US9226907B2
(en)
|
2008-02-01 |
2016-01-05 |
Abbvie Inc. |
Extended release hydrocodone acetaminophen and related methods and uses thereof
|
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
HRP20161307T1
(hr)
*
|
2008-05-09 |
2016-12-02 |
Grünenthal GmbH |
Postupak za pripravu praškaste formulacije međuproizvoda i konačni kruti oblik doziranja uz korištenje koraka zgrušavanja raspršivanjem
|
|
US8715706B2
(en)
|
2009-06-18 |
2014-05-06 |
RDD Pharma, Ltd. |
Methods and devices for delivery of pharmaceutical agents within orifices of the body
|
|
ES2428938T3
(es)
|
2009-07-22 |
2013-11-12 |
Grünenthal GmbH |
Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
|
|
ES2534908T3
(es)
|
2009-07-22 |
2015-04-30 |
Grünenthal GmbH |
Forma de dosificación de liberación controlada extruida por fusión en caliente
|
|
US9053844B2
(en)
*
|
2009-09-09 |
2015-06-09 |
Littelfuse, Inc. |
Geometric configuration or alignment of protective material in a gap structure for electrical devices
|
|
NZ598686A
(en)
|
2009-09-28 |
2014-05-30 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
EP2531176B1
(en)
*
|
2010-02-03 |
2016-09-07 |
Grünenthal GmbH |
Preparation of a powdery pharmaceutical composition by means of an extruder
|
|
AU2011297892B2
(en)
|
2010-09-02 |
2014-05-29 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising an anionic polymer
|
|
AU2011297901B2
(en)
|
2010-09-02 |
2014-07-31 |
Grunenthal Gmbh |
Tamper resistant dosage form comprising inorganic salt
|
|
US9000046B2
(en)
|
2010-09-28 |
2015-04-07 |
Depomed, Inc. |
Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
AU2012292418B2
(en)
|
2011-07-29 |
2017-02-16 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
|
RS56528B1
(sr)
|
2011-07-29 |
2018-02-28 |
Gruenenthal Gmbh |
Tableta za trenutno oslobađanje leka rezistentna na zloupotrebu
|
|
EP2819656A1
(en)
|
2012-02-28 |
2015-01-07 |
Grünenthal GmbH |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
|
EP2838512B1
(en)
|
2012-04-18 |
2018-08-22 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
|
US20140088345A1
(en)
*
|
2012-09-27 |
2014-03-27 |
Palo Alto Research Center Incorporated |
Single channel, multiple drug delivery device and methods
|
|
AU2014273227B2
(en)
|
2013-05-29 |
2019-08-15 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
|
BR112015029616A2
(pt)
|
2013-05-29 |
2017-07-25 |
Gruenenthal Gmbh |
forma de dosagem resistente à adulteração com perfil de liberação bimodal
|
|
CA2917136C
(en)
|
2013-07-12 |
2022-05-31 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
|
BR112016010482B1
(pt)
|
2013-11-26 |
2022-11-16 |
Grünenthal GmbH |
Preparação de uma composição farmacêutica em pó por meio de criomoagem
|
|
EP3076946A1
(en)
*
|
2013-12-06 |
2016-10-12 |
Durect Corporation |
Compositions comprising antioxidant, fluid dispensers, and methods involving the same
|
|
US9297083B2
(en)
|
2013-12-16 |
2016-03-29 |
Palo Alto Research Center Incorporated |
Electrolytic gas generating devices, actuators, and methods
|
|
JP2017518980A
(ja)
|
2014-05-12 |
2017-07-13 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
タペンタドールを含む、改変防止即時放出カプセル製剤
|
|
CA2949422A1
(en)
|
2014-05-26 |
2015-12-03 |
Grunenthal Gmbh |
Multiparticles safeguarded against ethanolic dose-dumping
|
|
US10278675B2
(en)
|
2014-07-31 |
2019-05-07 |
Palo Alto Research Center Incorporated |
Implantable estrus detection devices, systems, and methods
|
|
US9801660B2
(en)
|
2014-07-31 |
2017-10-31 |
Palo Alto Research Center Incorporated |
Implantable fluid delivery devices, systems, and methods
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
MX2017013637A
(es)
|
2015-04-24 |
2018-03-08 |
Gruenenthal Gmbh |
Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
|
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
WO2017042325A1
(en)
|
2015-09-10 |
2017-03-16 |
Grünenthal GmbH |
Protecting oral overdose with abuse deterrent immediate release formulations
|
|
JP7077237B2
(ja)
|
2016-05-16 |
2022-05-30 |
インターシア セラピューティクス，インコーポレイティド |
グルカゴン受容体選択的ポリペプチド及びその使用方法
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
MX2019008006A
(es)
|
2017-01-03 |
2019-08-29 |
Intarcia Therapeutics Inc |
Metodos que comprenden la administracion continua de un agonista del receptor de glp-1 y la co-administracion de un farmaco.
|
|
US9707217B1
(en)
|
2017-02-03 |
2017-07-18 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dose-dumping resistant controlled release dosage form
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
FI4037666T3
(fi)
|
2020-12-08 |
2024-06-24 |
Ruminant Biotech Corp Ltd |
Parannuksia laitteisiin ja menetelmiin aineiden toimittamiseksi eläimille
|